SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Hexstone Capital Files Schedule 13G for Actuate Therapeutics

Hexstone Capital LLC filed a Schedule 13G for Actuate Therapeutics. The filing date is shown as October 30, 20.

ACTU

Related stories